It has been determined in breast carcinoma that the ChREBP protein levels are low in the first stages (I and II) of cancer development but increase once the malignant phenotype progresses (stages III and IV); thus, it has been considered to be a promising malignancy marker [147]. The gene discussed is MLXIPL; the disease is cancer.